nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—Procainamide—Sunitinib—kidney cancer	0.559	1	CrCrCtD
Moclobemide—CYP2D6—Temsirolimus—kidney cancer	0.045	0.171	CbGbCtD
Moclobemide—CYP1A2—Pazopanib—kidney cancer	0.0287	0.109	CbGbCtD
Moclobemide—CYP2C9—Capecitabine—kidney cancer	0.027	0.102	CbGbCtD
Moclobemide—CYP2D6—Pazopanib—kidney cancer	0.0236	0.0896	CbGbCtD
Moclobemide—CYP1A2—Erlotinib—kidney cancer	0.0205	0.0776	CbGbCtD
Moclobemide—CYP2C19—Sorafenib—kidney cancer	0.018	0.0684	CbGbCtD
Moclobemide—CYP2C9—Paclitaxel—kidney cancer	0.0169	0.064	CbGbCtD
Moclobemide—CYP2D6—Erlotinib—kidney cancer	0.0169	0.0639	CbGbCtD
Moclobemide—CYP1A2—Sorafenib—kidney cancer	0.0166	0.0631	CbGbCtD
Moclobemide—CYP2C9—Sorafenib—kidney cancer	0.015	0.0569	CbGbCtD
Moclobemide—CYP2D6—Sorafenib—kidney cancer	0.0137	0.052	CbGbCtD
Moclobemide—CYP2D6—Vinblastine—kidney cancer	0.0135	0.0513	CbGbCtD
Moclobemide—CYP2D6—Doxorubicin—kidney cancer	0.00832	0.0315	CbGbCtD
Moclobemide—CYP2C19—urine—kidney cancer	0.0028	0.161	CbGeAlD
Moclobemide—CYP1A2—urine—kidney cancer	0.00228	0.132	CbGeAlD
Moclobemide—CYP2C9—urine—kidney cancer	0.00217	0.125	CbGeAlD
Moclobemide—CYP2D6—urine—kidney cancer	0.00163	0.0937	CbGeAlD
Moclobemide—Minaprine—ACHE—kidney cancer	0.00147	0.424	CrCbGaD
Moclobemide—MAOB—nephron tubule—kidney cancer	0.000863	0.0498	CbGeAlD
Moclobemide—MAOB—renal system—kidney cancer	0.000785	0.0452	CbGeAlD
Moclobemide—MAOB—kidney—kidney cancer	0.000759	0.0437	CbGeAlD
Moclobemide—MAOB—cortex of kidney—kidney cancer	0.000739	0.0426	CbGeAlD
Moclobemide—MAOA—nephron tubule—kidney cancer	0.000737	0.0425	CbGeAlD
Moclobemide—MAOB—cardiac atrium—kidney cancer	0.000703	0.0405	CbGeAlD
Moclobemide—Procainamide—ACHE—kidney cancer	0.000676	0.195	CrCbGaD
Moclobemide—MAOA—renal system—kidney cancer	0.00067	0.0386	CbGeAlD
Moclobemide—MAOA—kidney—kidney cancer	0.000647	0.0373	CbGeAlD
Moclobemide—MAOA—cortex of kidney—kidney cancer	0.00063	0.0363	CbGeAlD
Moclobemide—MAOA—cardiac atrium—kidney cancer	0.0006	0.0346	CbGeAlD
Moclobemide—CYP1A2—renal system—kidney cancer	0.000559	0.0322	CbGeAlD
Moclobemide—Bezafibrate—CYP1A1—kidney cancer	0.000466	0.134	CrCbGaD
Moclobemide—CYP2D6—renal system—kidney cancer	0.000398	0.0229	CbGeAlD
Moclobemide—Procainamide—BCHE—kidney cancer	0.000398	0.114	CrCbGaD
Moclobemide—CYP2D6—kidney—kidney cancer	0.000385	0.0222	CbGeAlD
Moclobemide—Haloperidol—CYP1A1—kidney cancer	0.000302	0.0869	CrCbGaD
Moclobemide—Constipation—Sunitinib—kidney cancer	0.000188	0.00146	CcSEcCtD
Moclobemide—Gastrointestinal pain—Sorafenib—kidney cancer	0.000187	0.00145	CcSEcCtD
Moclobemide—Hypertension—Gemcitabine—kidney cancer	0.000186	0.00145	CcSEcCtD
Moclobemide—Pruritus—Everolimus—kidney cancer	0.000186	0.00145	CcSEcCtD
Moclobemide—Stomatitis—Capecitabine—kidney cancer	0.000185	0.00144	CcSEcCtD
Moclobemide—Conjunctivitis—Capecitabine—kidney cancer	0.000185	0.00144	CcSEcCtD
Moclobemide—Chest pain—Gemcitabine—kidney cancer	0.000184	0.00143	CcSEcCtD
Moclobemide—Myalgia—Gemcitabine—kidney cancer	0.000184	0.00143	CcSEcCtD
Moclobemide—Asthenia—Erlotinib—kidney cancer	0.000182	0.00142	CcSEcCtD
Moclobemide—Discomfort—Gemcitabine—kidney cancer	0.000182	0.00141	CcSEcCtD
Moclobemide—Urticaria—Sorafenib—kidney cancer	0.000181	0.00141	CcSEcCtD
Moclobemide—Decreased appetite—Dactinomycin—kidney cancer	0.000181	0.00141	CcSEcCtD
Moclobemide—Diarrhoea—Vinblastine—kidney cancer	0.000181	0.00141	CcSEcCtD
Moclobemide—Abdominal pain—Sorafenib—kidney cancer	0.00018	0.0014	CcSEcCtD
Moclobemide—Diarrhoea—Everolimus—kidney cancer	0.00018	0.0014	CcSEcCtD
Moclobemide—Gastrointestinal pain—Sunitinib—kidney cancer	0.00018	0.0014	CcSEcCtD
Moclobemide—Hyperhidrosis—Vincristine—kidney cancer	0.00018	0.0014	CcSEcCtD
Moclobemide—Pruritus—Erlotinib—kidney cancer	0.000179	0.0014	CcSEcCtD
Moclobemide—Fatigue—Dactinomycin—kidney cancer	0.000179	0.0014	CcSEcCtD
Moclobemide—Flatulence—Paclitaxel—kidney cancer	0.000178	0.00139	CcSEcCtD
Moclobemide—Tension—Paclitaxel—kidney cancer	0.000177	0.00138	CcSEcCtD
Moclobemide—Dysgeusia—Paclitaxel—kidney cancer	0.000177	0.00138	CcSEcCtD
Moclobemide—Nervousness—Paclitaxel—kidney cancer	0.000176	0.00137	CcSEcCtD
Moclobemide—Dizziness—Vinblastine—kidney cancer	0.000175	0.00136	CcSEcCtD
Moclobemide—Dizziness—Everolimus—kidney cancer	0.000174	0.00135	CcSEcCtD
Moclobemide—Abdominal pain—Sunitinib—kidney cancer	0.000174	0.00135	CcSEcCtD
Moclobemide—Diarrhoea—Erlotinib—kidney cancer	0.000174	0.00135	CcSEcCtD
Moclobemide—Hypotension—Vincristine—kidney cancer	0.000174	0.00135	CcSEcCtD
Moclobemide—Bradycardia—Capecitabine—kidney cancer	0.000173	0.00135	CcSEcCtD
Moclobemide—Feeling abnormal—Dactinomycin—kidney cancer	0.000171	0.00133	CcSEcCtD
Moclobemide—Vision blurred—Paclitaxel—kidney cancer	0.00017	0.00133	CcSEcCtD
Moclobemide—Hyperhidrosis—Gemcitabine—kidney cancer	0.00017	0.00133	CcSEcCtD
Moclobemide—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00017	0.00132	CcSEcCtD
Moclobemide—Hot flush—Doxorubicin—kidney cancer	0.00017	0.00132	CcSEcCtD
Moclobemide—Tremor—Paclitaxel—kidney cancer	0.000169	0.00132	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000169	0.00132	CcSEcCtD
Moclobemide—Menopausal symptoms—Doxorubicin—kidney cancer	0.000168	0.00131	CcSEcCtD
Moclobemide—Insomnia—Vincristine—kidney cancer	0.000168	0.00131	CcSEcCtD
Moclobemide—Vomiting—Vinblastine—kidney cancer	0.000168	0.00131	CcSEcCtD
Moclobemide—Dizziness—Erlotinib—kidney cancer	0.000168	0.00131	CcSEcCtD
Moclobemide—Ill-defined disorder—Paclitaxel—kidney cancer	0.000168	0.00131	CcSEcCtD
Moclobemide—Vomiting—Everolimus—kidney cancer	0.000167	0.0013	CcSEcCtD
Moclobemide—Paraesthesia—Vincristine—kidney cancer	0.000167	0.0013	CcSEcCtD
Moclobemide—Agitation—Paclitaxel—kidney cancer	0.000166	0.00129	CcSEcCtD
Moclobemide—Rash—Everolimus—kidney cancer	0.000166	0.00129	CcSEcCtD
Moclobemide—Dermatitis—Everolimus—kidney cancer	0.000166	0.00129	CcSEcCtD
Moclobemide—Headache—Vinblastine—kidney cancer	0.000165	0.00129	CcSEcCtD
Moclobemide—Headache—Everolimus—kidney cancer	0.000165	0.00128	CcSEcCtD
Moclobemide—Hypotension—Gemcitabine—kidney cancer	0.000165	0.00128	CcSEcCtD
Moclobemide—Abdominal pain—Dactinomycin—kidney cancer	0.000164	0.00128	CcSEcCtD
Moclobemide—Visual impairment—Capecitabine—kidney cancer	0.000164	0.00128	CcSEcCtD
Moclobemide—Asthenia—Sorafenib—kidney cancer	0.000164	0.00127	CcSEcCtD
Moclobemide—Malaise—Paclitaxel—kidney cancer	0.000163	0.00127	CcSEcCtD
Moclobemide—Syncope—Paclitaxel—kidney cancer	0.000162	0.00126	CcSEcCtD
Moclobemide—Decreased appetite—Vincristine—kidney cancer	0.000161	0.00126	CcSEcCtD
Moclobemide—Pruritus—Sorafenib—kidney cancer	0.000161	0.00126	CcSEcCtD
Moclobemide—Vomiting—Erlotinib—kidney cancer	0.000161	0.00126	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000161	0.00125	CcSEcCtD
Moclobemide—Haloperidol—ABCB1—kidney cancer	0.00016	0.0462	CrCbGaD
Moclobemide—Fatigue—Vincristine—kidney cancer	0.00016	0.00125	CcSEcCtD
Moclobemide—Rash—Erlotinib—kidney cancer	0.00016	0.00125	CcSEcCtD
Moclobemide—Dermatitis—Erlotinib—kidney cancer	0.00016	0.00124	CcSEcCtD
Moclobemide—Palpitations—Paclitaxel—kidney cancer	0.00016	0.00124	CcSEcCtD
Moclobemide—Insomnia—Gemcitabine—kidney cancer	0.000159	0.00124	CcSEcCtD
Moclobemide—Headache—Erlotinib—kidney cancer	0.000159	0.00124	CcSEcCtD
Moclobemide—Tinnitus—Capecitabine—kidney cancer	0.000159	0.00124	CcSEcCtD
Moclobemide—Loss of consciousness—Paclitaxel—kidney cancer	0.000159	0.00124	CcSEcCtD
Moclobemide—Constipation—Vincristine—kidney cancer	0.000159	0.00124	CcSEcCtD
Moclobemide—Osteoarthritis—Doxorubicin—kidney cancer	0.000159	0.00124	CcSEcCtD
Moclobemide—Paraesthesia—Gemcitabine—kidney cancer	0.000158	0.00123	CcSEcCtD
Moclobemide—Flushing—Capecitabine—kidney cancer	0.000158	0.00123	CcSEcCtD
Moclobemide—Asthenia—Sunitinib—kidney cancer	0.000158	0.00123	CcSEcCtD
Moclobemide—Dyspnoea—Gemcitabine—kidney cancer	0.000157	0.00122	CcSEcCtD
Moclobemide—Nausea—Vinblastine—kidney cancer	0.000157	0.00122	CcSEcCtD
Moclobemide—Somnolence—Gemcitabine—kidney cancer	0.000157	0.00122	CcSEcCtD
Moclobemide—Migraine—Doxorubicin—kidney cancer	0.000156	0.00122	CcSEcCtD
Moclobemide—Nausea—Everolimus—kidney cancer	0.000156	0.00122	CcSEcCtD
Moclobemide—Diarrhoea—Sorafenib—kidney cancer	0.000156	0.00122	CcSEcCtD
Moclobemide—Hypertension—Paclitaxel—kidney cancer	0.000156	0.00122	CcSEcCtD
Moclobemide—Pruritus—Sunitinib—kidney cancer	0.000155	0.00121	CcSEcCtD
Moclobemide—Myalgia—Paclitaxel—kidney cancer	0.000154	0.0012	CcSEcCtD
Moclobemide—Chest pain—Paclitaxel—kidney cancer	0.000154	0.0012	CcSEcCtD
Moclobemide—Anxiety—Paclitaxel—kidney cancer	0.000153	0.00119	CcSEcCtD
Moclobemide—Decreased appetite—Gemcitabine—kidney cancer	0.000153	0.00119	CcSEcCtD
Moclobemide—Discomfort—Paclitaxel—kidney cancer	0.000152	0.00118	CcSEcCtD
Moclobemide—Fatigue—Gemcitabine—kidney cancer	0.000152	0.00118	CcSEcCtD
Moclobemide—Gastrointestinal pain—Vincristine—kidney cancer	0.000152	0.00118	CcSEcCtD
Moclobemide—Dizziness—Sorafenib—kidney cancer	0.000151	0.00118	CcSEcCtD
Moclobemide—Constipation—Gemcitabine—kidney cancer	0.000151	0.00117	CcSEcCtD
Moclobemide—Nausea—Erlotinib—kidney cancer	0.000151	0.00117	CcSEcCtD
Moclobemide—Dry mouth—Paclitaxel—kidney cancer	0.000151	0.00117	CcSEcCtD
Moclobemide—Diarrhoea—Sunitinib—kidney cancer	0.00015	0.00117	CcSEcCtD
Moclobemide—Asthenia—Dactinomycin—kidney cancer	0.000149	0.00116	CcSEcCtD
Moclobemide—Confusional state—Paclitaxel—kidney cancer	0.000149	0.00116	CcSEcCtD
Moclobemide—Abdominal pain—Vincristine—kidney cancer	0.000147	0.00114	CcSEcCtD
Moclobemide—Flatulence—Capecitabine—kidney cancer	0.000146	0.00114	CcSEcCtD
Moclobemide—Dry skin—Doxorubicin—kidney cancer	0.000146	0.00113	CcSEcCtD
Moclobemide—Dysgeusia—Capecitabine—kidney cancer	0.000145	0.00113	CcSEcCtD
Moclobemide—Dizziness—Sunitinib—kidney cancer	0.000145	0.00113	CcSEcCtD
Moclobemide—Feeling abnormal—Gemcitabine—kidney cancer	0.000145	0.00113	CcSEcCtD
Moclobemide—Shock—Paclitaxel—kidney cancer	0.000145	0.00113	CcSEcCtD
Moclobemide—Vomiting—Sorafenib—kidney cancer	0.000145	0.00113	CcSEcCtD
Moclobemide—Tachycardia—Paclitaxel—kidney cancer	0.000144	0.00112	CcSEcCtD
Moclobemide—Rash—Sorafenib—kidney cancer	0.000144	0.00112	CcSEcCtD
Moclobemide—Dermatitis—Sorafenib—kidney cancer	0.000144	0.00112	CcSEcCtD
Moclobemide—Headache—Sorafenib—kidney cancer	0.000143	0.00111	CcSEcCtD
Moclobemide—Hyperhidrosis—Paclitaxel—kidney cancer	0.000143	0.00111	CcSEcCtD
Moclobemide—Diarrhoea—Dactinomycin—kidney cancer	0.000142	0.00111	CcSEcCtD
Moclobemide—Gastritis—Doxorubicin—kidney cancer	0.000141	0.00109	CcSEcCtD
Moclobemide—Vision blurred—Capecitabine—kidney cancer	0.00014	0.00109	CcSEcCtD
Moclobemide—Vomiting—Sunitinib—kidney cancer	0.00014	0.00109	CcSEcCtD
Moclobemide—Tremor—Capecitabine—kidney cancer	0.000139	0.00108	CcSEcCtD
Moclobemide—Rash—Sunitinib—kidney cancer	0.000138	0.00108	CcSEcCtD
Moclobemide—Dermatitis—Sunitinib—kidney cancer	0.000138	0.00108	CcSEcCtD
Moclobemide—Abdominal distension—Doxorubicin—kidney cancer	0.000138	0.00108	CcSEcCtD
Moclobemide—Hypotension—Paclitaxel—kidney cancer	0.000138	0.00107	CcSEcCtD
Moclobemide—Ill-defined disorder—Capecitabine—kidney cancer	0.000138	0.00107	CcSEcCtD
Moclobemide—Headache—Sunitinib—kidney cancer	0.000138	0.00107	CcSEcCtD
Moclobemide—Nausea—Sorafenib—kidney cancer	0.000136	0.00106	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000134	0.00105	CcSEcCtD
Moclobemide—Malaise—Capecitabine—kidney cancer	0.000134	0.00104	CcSEcCtD
Moclobemide—Angina pectoris—Doxorubicin—kidney cancer	0.000134	0.00104	CcSEcCtD
Moclobemide—Insomnia—Paclitaxel—kidney cancer	0.000133	0.00104	CcSEcCtD
Moclobemide—Asthenia—Vincristine—kidney cancer	0.000133	0.00104	CcSEcCtD
Moclobemide—Syncope—Capecitabine—kidney cancer	0.000133	0.00104	CcSEcCtD
Moclobemide—Paraesthesia—Paclitaxel—kidney cancer	0.000132	0.00103	CcSEcCtD
Moclobemide—Vomiting—Dactinomycin—kidney cancer	0.000132	0.00103	CcSEcCtD
Moclobemide—Dyspnoea—Paclitaxel—kidney cancer	0.000132	0.00102	CcSEcCtD
Moclobemide—Somnolence—Paclitaxel—kidney cancer	0.000131	0.00102	CcSEcCtD
Moclobemide—Palpitations—Capecitabine—kidney cancer	0.000131	0.00102	CcSEcCtD
Moclobemide—Rash—Dactinomycin—kidney cancer	0.000131	0.00102	CcSEcCtD
Moclobemide—Nausea—Sunitinib—kidney cancer	0.00013	0.00102	CcSEcCtD
Moclobemide—Loss of consciousness—Capecitabine—kidney cancer	0.00013	0.00102	CcSEcCtD
Moclobemide—Dyspepsia—Paclitaxel—kidney cancer	0.00013	0.00101	CcSEcCtD
Moclobemide—Dysuria—Doxorubicin—kidney cancer	0.000128	0.000999	CcSEcCtD
Moclobemide—Decreased appetite—Paclitaxel—kidney cancer	0.000128	0.000999	CcSEcCtD
Moclobemide—Hypertension—Capecitabine—kidney cancer	0.000128	0.000997	CcSEcCtD
Moclobemide—Fatigue—Paclitaxel—kidney cancer	0.000127	0.00099	CcSEcCtD
Moclobemide—Diarrhoea—Vincristine—kidney cancer	0.000127	0.000989	CcSEcCtD
Moclobemide—Asthenia—Gemcitabine—kidney cancer	0.000126	0.000984	CcSEcCtD
Moclobemide—Myalgia—Capecitabine—kidney cancer	0.000126	0.000983	CcSEcCtD
Moclobemide—Chest pain—Capecitabine—kidney cancer	0.000126	0.000983	CcSEcCtD
Moclobemide—Constipation—Paclitaxel—kidney cancer	0.000126	0.000982	CcSEcCtD
Moclobemide—Anxiety—Capecitabine—kidney cancer	0.000126	0.00098	CcSEcCtD
Moclobemide—Discomfort—Capecitabine—kidney cancer	0.000125	0.000972	CcSEcCtD
Moclobemide—Pruritus—Gemcitabine—kidney cancer	0.000125	0.000971	CcSEcCtD
Moclobemide—Dry mouth—Capecitabine—kidney cancer	0.000124	0.000962	CcSEcCtD
Moclobemide—Nausea—Dactinomycin—kidney cancer	0.000123	0.000961	CcSEcCtD
Moclobemide—Dizziness—Vincristine—kidney cancer	0.000123	0.000956	CcSEcCtD
Moclobemide—Drowsiness—Doxorubicin—kidney cancer	0.000122	0.000953	CcSEcCtD
Moclobemide—Confusional state—Capecitabine—kidney cancer	0.000122	0.00095	CcSEcCtD
Moclobemide—Feeling abnormal—Paclitaxel—kidney cancer	0.000122	0.000947	CcSEcCtD
Moclobemide—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000121	0.000939	CcSEcCtD
Moclobemide—Diarrhoea—Gemcitabine—kidney cancer	0.000121	0.000939	CcSEcCtD
Moclobemide—Stomatitis—Doxorubicin—kidney cancer	0.000119	0.000929	CcSEcCtD
Moclobemide—Shock—Capecitabine—kidney cancer	0.000119	0.000927	CcSEcCtD
Moclobemide—Conjunctivitis—Doxorubicin—kidney cancer	0.000119	0.000926	CcSEcCtD
Moclobemide—Tachycardia—Capecitabine—kidney cancer	0.000118	0.00092	CcSEcCtD
Moclobemide—Vomiting—Vincristine—kidney cancer	0.000118	0.00092	CcSEcCtD
Moclobemide—Sweating—Doxorubicin—kidney cancer	0.000117	0.000913	CcSEcCtD
Moclobemide—Urticaria—Paclitaxel—kidney cancer	0.000117	0.000913	CcSEcCtD
Moclobemide—Rash—Vincristine—kidney cancer	0.000117	0.000912	CcSEcCtD
Moclobemide—Hyperhidrosis—Capecitabine—kidney cancer	0.000117	0.000911	CcSEcCtD
Moclobemide—Dermatitis—Vincristine—kidney cancer	0.000117	0.000911	CcSEcCtD
Moclobemide—Abdominal pain—Paclitaxel—kidney cancer	0.000117	0.000908	CcSEcCtD
Moclobemide—Headache—Vincristine—kidney cancer	0.000116	0.000906	CcSEcCtD
Moclobemide—Hypotension—Capecitabine—kidney cancer	0.000113	0.000881	CcSEcCtD
Moclobemide—Vomiting—Gemcitabine—kidney cancer	0.000112	0.000872	CcSEcCtD
Moclobemide—Bradycardia—Doxorubicin—kidney cancer	0.000112	0.000871	CcSEcCtD
Moclobemide—Rash—Gemcitabine—kidney cancer	0.000111	0.000865	CcSEcCtD
Moclobemide—Dermatitis—Gemcitabine—kidney cancer	0.000111	0.000864	CcSEcCtD
Moclobemide—Headache—Gemcitabine—kidney cancer	0.00011	0.000859	CcSEcCtD
Moclobemide—Nausea—Vincristine—kidney cancer	0.00011	0.000859	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.00011	0.000859	CcSEcCtD
Moclobemide—Insomnia—Capecitabine—kidney cancer	0.000109	0.000853	CcSEcCtD
Moclobemide—Paraesthesia—Capecitabine—kidney cancer	0.000109	0.000846	CcSEcCtD
Moclobemide—Dyspnoea—Capecitabine—kidney cancer	0.000108	0.00084	CcSEcCtD
Moclobemide—Dyspepsia—Capecitabine—kidney cancer	0.000107	0.00083	CcSEcCtD
Moclobemide—Visual impairment—Doxorubicin—kidney cancer	0.000106	0.000824	CcSEcCtD
Moclobemide—Asthenia—Paclitaxel—kidney cancer	0.000106	0.000824	CcSEcCtD
Moclobemide—Decreased appetite—Capecitabine—kidney cancer	0.000105	0.000819	CcSEcCtD
Moclobemide—Nausea—Gemcitabine—kidney cancer	0.000105	0.000815	CcSEcCtD
Moclobemide—Fatigue—Capecitabine—kidney cancer	0.000104	0.000813	CcSEcCtD
Moclobemide—Pruritus—Paclitaxel—kidney cancer	0.000104	0.000813	CcSEcCtD
Moclobemide—Constipation—Capecitabine—kidney cancer	0.000104	0.000806	CcSEcCtD
Moclobemide—Tinnitus—Doxorubicin—kidney cancer	0.000102	0.000797	CcSEcCtD
Moclobemide—Flushing—Doxorubicin—kidney cancer	0.000102	0.000794	CcSEcCtD
Moclobemide—Diarrhoea—Paclitaxel—kidney cancer	0.000101	0.000786	CcSEcCtD
Moclobemide—Feeling abnormal—Capecitabine—kidney cancer	9.98e-05	0.000777	CcSEcCtD
Moclobemide—Gastrointestinal pain—Capecitabine—kidney cancer	9.9e-05	0.000771	CcSEcCtD
Moclobemide—Dizziness—Paclitaxel—kidney cancer	9.76e-05	0.00076	CcSEcCtD
Moclobemide—Urticaria—Capecitabine—kidney cancer	9.62e-05	0.000749	CcSEcCtD
Moclobemide—Abdominal pain—Capecitabine—kidney cancer	9.57e-05	0.000745	CcSEcCtD
Moclobemide—Flatulence—Doxorubicin—kidney cancer	9.42e-05	0.000734	CcSEcCtD
Moclobemide—Tension—Doxorubicin—kidney cancer	9.38e-05	0.000731	CcSEcCtD
Moclobemide—Vomiting—Paclitaxel—kidney cancer	9.38e-05	0.00073	CcSEcCtD
Moclobemide—Dysgeusia—Doxorubicin—kidney cancer	9.36e-05	0.000729	CcSEcCtD
Moclobemide—Rash—Paclitaxel—kidney cancer	9.3e-05	0.000724	CcSEcCtD
Moclobemide—Dermatitis—Paclitaxel—kidney cancer	9.29e-05	0.000724	CcSEcCtD
Moclobemide—Nervousness—Doxorubicin—kidney cancer	9.29e-05	0.000723	CcSEcCtD
Moclobemide—Headache—Paclitaxel—kidney cancer	9.24e-05	0.00072	CcSEcCtD
Moclobemide—Vision blurred—Doxorubicin—kidney cancer	9.01e-05	0.000702	CcSEcCtD
Moclobemide—Ill-defined disorder—Doxorubicin—kidney cancer	8.87e-05	0.000691	CcSEcCtD
Moclobemide—Agitation—Doxorubicin—kidney cancer	8.79e-05	0.000684	CcSEcCtD
Moclobemide—Nausea—Paclitaxel—kidney cancer	8.76e-05	0.000682	CcSEcCtD
Moclobemide—Asthenia—Capecitabine—kidney cancer	8.69e-05	0.000676	CcSEcCtD
Moclobemide—Malaise—Doxorubicin—kidney cancer	8.62e-05	0.000671	CcSEcCtD
Moclobemide—Syncope—Doxorubicin—kidney cancer	8.58e-05	0.000668	CcSEcCtD
Moclobemide—Pruritus—Capecitabine—kidney cancer	8.57e-05	0.000667	CcSEcCtD
Moclobemide—Palpitations—Doxorubicin—kidney cancer	8.45e-05	0.000658	CcSEcCtD
Moclobemide—Loss of consciousness—Doxorubicin—kidney cancer	8.4e-05	0.000654	CcSEcCtD
Moclobemide—Diarrhoea—Capecitabine—kidney cancer	8.28e-05	0.000645	CcSEcCtD
Moclobemide—Hypertension—Doxorubicin—kidney cancer	8.26e-05	0.000643	CcSEcCtD
Moclobemide—Chest pain—Doxorubicin—kidney cancer	8.14e-05	0.000634	CcSEcCtD
Moclobemide—Myalgia—Doxorubicin—kidney cancer	8.14e-05	0.000634	CcSEcCtD
Moclobemide—Anxiety—Doxorubicin—kidney cancer	8.11e-05	0.000632	CcSEcCtD
Moclobemide—Discomfort—Doxorubicin—kidney cancer	8.04e-05	0.000626	CcSEcCtD
Moclobemide—Dizziness—Capecitabine—kidney cancer	8.01e-05	0.000623	CcSEcCtD
Moclobemide—Dry mouth—Doxorubicin—kidney cancer	7.96e-05	0.00062	CcSEcCtD
Moclobemide—Confusional state—Doxorubicin—kidney cancer	7.87e-05	0.000613	CcSEcCtD
Moclobemide—Vomiting—Capecitabine—kidney cancer	7.7e-05	0.000599	CcSEcCtD
Moclobemide—Shock—Doxorubicin—kidney cancer	7.68e-05	0.000598	CcSEcCtD
Moclobemide—Rash—Capecitabine—kidney cancer	7.63e-05	0.000594	CcSEcCtD
Moclobemide—Dermatitis—Capecitabine—kidney cancer	7.63e-05	0.000594	CcSEcCtD
Moclobemide—Tachycardia—Doxorubicin—kidney cancer	7.62e-05	0.000593	CcSEcCtD
Moclobemide—Headache—Capecitabine—kidney cancer	7.58e-05	0.000591	CcSEcCtD
Moclobemide—Hyperhidrosis—Doxorubicin—kidney cancer	7.54e-05	0.000587	CcSEcCtD
Moclobemide—Hypotension—Doxorubicin—kidney cancer	7.29e-05	0.000568	CcSEcCtD
Moclobemide—Nausea—Capecitabine—kidney cancer	7.19e-05	0.00056	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	7.11e-05	0.000554	CcSEcCtD
Moclobemide—Insomnia—Doxorubicin—kidney cancer	7.06e-05	0.00055	CcSEcCtD
Moclobemide—Paraesthesia—Doxorubicin—kidney cancer	7.01e-05	0.000546	CcSEcCtD
Moclobemide—Dyspnoea—Doxorubicin—kidney cancer	6.96e-05	0.000542	CcSEcCtD
Moclobemide—Somnolence—Doxorubicin—kidney cancer	6.94e-05	0.00054	CcSEcCtD
Moclobemide—Dyspepsia—Doxorubicin—kidney cancer	6.87e-05	0.000535	CcSEcCtD
Moclobemide—Decreased appetite—Doxorubicin—kidney cancer	6.78e-05	0.000528	CcSEcCtD
Moclobemide—Fatigue—Doxorubicin—kidney cancer	6.73e-05	0.000524	CcSEcCtD
Moclobemide—Constipation—Doxorubicin—kidney cancer	6.67e-05	0.00052	CcSEcCtD
Moclobemide—Feeling abnormal—Doxorubicin—kidney cancer	6.43e-05	0.000501	CcSEcCtD
Moclobemide—Gastrointestinal pain—Doxorubicin—kidney cancer	6.38e-05	0.000497	CcSEcCtD
Moclobemide—Urticaria—Doxorubicin—kidney cancer	6.2e-05	0.000483	CcSEcCtD
Moclobemide—Abdominal pain—Doxorubicin—kidney cancer	6.17e-05	0.00048	CcSEcCtD
Moclobemide—Asthenia—Doxorubicin—kidney cancer	5.6e-05	0.000436	CcSEcCtD
Moclobemide—Pruritus—Doxorubicin—kidney cancer	5.52e-05	0.00043	CcSEcCtD
Moclobemide—Diarrhoea—Doxorubicin—kidney cancer	5.34e-05	0.000416	CcSEcCtD
Moclobemide—Dizziness—Doxorubicin—kidney cancer	5.16e-05	0.000402	CcSEcCtD
Moclobemide—Vomiting—Doxorubicin—kidney cancer	4.96e-05	0.000386	CcSEcCtD
Moclobemide—Rash—Doxorubicin—kidney cancer	4.92e-05	0.000383	CcSEcCtD
Moclobemide—Dermatitis—Doxorubicin—kidney cancer	4.92e-05	0.000383	CcSEcCtD
Moclobemide—Headache—Doxorubicin—kidney cancer	4.89e-05	0.000381	CcSEcCtD
Moclobemide—Nausea—Doxorubicin—kidney cancer	4.64e-05	0.000361	CcSEcCtD
Moclobemide—CYP2C19—Biological oxidations—GSTP1—kidney cancer	3.26e-05	0.00119	CbGpPWpGaD
Moclobemide—CYP2C19—Metapathway biotransformation—GSTP1—kidney cancer	3.22e-05	0.00118	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GPC3—kidney cancer	3.2e-05	0.00117	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CRABP1—kidney cancer	3.2e-05	0.00117	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CA2—kidney cancer	3.11e-05	0.00114	CbGpPWpGaD
Moclobemide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.11e-05	0.00114	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—VEGFA—kidney cancer	3.04e-05	0.00111	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ALAD—kidney cancer	3.04e-05	0.00111	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	3.03e-05	0.00111	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—BRAF—kidney cancer	3e-05	0.0011	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—GSTP1—kidney cancer	3e-05	0.0011	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—GSTM1—kidney cancer	3e-05	0.0011	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	2.98e-05	0.00109	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—GSTP1—kidney cancer	2.98e-05	0.00109	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ITPR2—kidney cancer	2.97e-05	0.00109	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ST3GAL2—kidney cancer	2.96e-05	0.00108	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	2.96e-05	0.00108	CbGpPWpGaD
Moclobemide—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	2.96e-05	0.00108	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	2.94e-05	0.00107	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ALDH1A1—kidney cancer	2.9e-05	0.00106	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	2.84e-05	0.00104	CbGpPWpGaD
Moclobemide—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	2.81e-05	0.00103	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—SLC5A3—kidney cancer	2.78e-05	0.00101	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PGK1—kidney cancer	2.78e-05	0.00101	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—GSTM1—kidney cancer	2.76e-05	0.00101	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	2.74e-05	0.001	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—GSTM1—kidney cancer	2.74e-05	0.001	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—LDHB—kidney cancer	2.72e-05	0.000995	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	2.72e-05	0.000995	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GSTT1—kidney cancer	2.71e-05	0.000991	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ACHE—kidney cancer	2.71e-05	0.000991	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	2.7e-05	0.000986	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	2.68e-05	0.000981	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	2.62e-05	0.000956	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	2.59e-05	0.000948	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	2.58e-05	0.000943	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—SCARB1—kidney cancer	2.57e-05	0.000938	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	2.56e-05	0.000935	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—GSTP1—kidney cancer	2.54e-05	0.00093	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTGS1—kidney cancer	2.54e-05	0.000929	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	2.53e-05	0.000926	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	2.51e-05	0.000917	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—RAF1—kidney cancer	2.51e-05	0.000917	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ACY1—kidney cancer	2.5e-05	0.000914	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PSMD7—kidney cancer	2.49e-05	0.000911	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—BCHE—kidney cancer	2.36e-05	0.000864	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CA9—kidney cancer	2.36e-05	0.000863	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—GSTM1—kidney cancer	2.34e-05	0.000854	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—SLC5A5—kidney cancer	2.33e-05	0.000853	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	2.31e-05	0.000843	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ACY1—kidney cancer	2.3e-05	0.000841	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ACY1—kidney cancer	2.28e-05	0.000834	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—SLC2A1—kidney cancer	2.25e-05	0.000824	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.25e-05	0.000821	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	2.22e-05	0.00081	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	2.19e-05	0.000799	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.13e-05	0.00078	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PDHB—kidney cancer	2.13e-05	0.000777	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—POMC—kidney cancer	2.12e-05	0.000775	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CRABP1—kidney cancer	2.01e-05	0.000734	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CCBL1—kidney cancer	2e-05	0.000731	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PDHB—kidney cancer	1.96e-05	0.000715	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—POMC—kidney cancer	1.95e-05	0.000713	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ACY1—kidney cancer	1.95e-05	0.000712	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.95e-05	0.000711	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PDHB—kidney cancer	1.94e-05	0.000709	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—POMC—kidney cancer	1.93e-05	0.000707	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GSTP1—kidney cancer	1.88e-05	0.000687	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ITPR2—kidney cancer	1.87e-05	0.000682	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CCBL1—kidney cancer	1.84e-05	0.000672	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CCBL1—kidney cancer	1.82e-05	0.000667	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.81e-05	0.000661	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ABCB1—kidney cancer	1.78e-05	0.00065	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GLIPR1—kidney cancer	1.73e-05	0.000634	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PPAT—kidney cancer	1.73e-05	0.000634	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GSTM1—kidney cancer	1.73e-05	0.000631	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—MAPK1—kidney cancer	1.72e-05	0.000629	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.71e-05	0.000626	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GSTT1—kidney cancer	1.7e-05	0.000622	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ACHE—kidney cancer	1.7e-05	0.000622	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.69e-05	0.000619	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.66e-05	0.000608	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PDHB—kidney cancer	1.66e-05	0.000606	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—POMC—kidney cancer	1.65e-05	0.000604	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.65e-05	0.000603	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYP1A1—kidney cancer	1.64e-05	0.000599	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—FH—kidney cancer	1.61e-05	0.000589	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—APRT—kidney cancer	1.61e-05	0.000589	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—SCARB1—kidney cancer	1.61e-05	0.000589	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GLIPR1—kidney cancer	1.59e-05	0.000583	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PPAT—kidney cancer	1.59e-05	0.000583	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTGS1—kidney cancer	1.59e-05	0.000583	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.58e-05	0.000578	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PPAT—kidney cancer	1.58e-05	0.000578	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.58e-05	0.000576	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PSMD7—kidney cancer	1.56e-05	0.000572	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.56e-05	0.000571	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CCBL1—kidney cancer	1.56e-05	0.00057	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.55e-05	0.000565	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GPC3—kidney cancer	1.52e-05	0.000554	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—APRT—kidney cancer	1.48e-05	0.000542	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—FH—kidney cancer	1.48e-05	0.000542	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—BCHE—kidney cancer	1.48e-05	0.000542	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CA2—kidney cancer	1.47e-05	0.000539	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—FH—kidney cancer	1.47e-05	0.000537	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—APRT—kidney cancer	1.47e-05	0.000537	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—SLC5A5—kidney cancer	1.46e-05	0.000535	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ALAD—kidney cancer	1.44e-05	0.000525	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.44e-05	0.000525	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—SLC2A1—kidney cancer	1.41e-05	0.000517	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.41e-05	0.000515	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ST3GAL2—kidney cancer	1.4e-05	0.000513	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GPC3—kidney cancer	1.39e-05	0.00051	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GPC3—kidney cancer	1.38e-05	0.000505	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.37e-05	0.000501	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CA2—kidney cancer	1.36e-05	0.000496	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.35e-05	0.000494	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PPAT—kidney cancer	1.35e-05	0.000494	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CA2—kidney cancer	1.34e-05	0.000491	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.33e-05	0.000488	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALAD—kidney cancer	1.32e-05	0.000483	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.32e-05	0.000483	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PGK1—kidney cancer	1.31e-05	0.00048	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.31e-05	0.00048	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALAD—kidney cancer	1.31e-05	0.000479	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.29e-05	0.000471	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—LDHB—kidney cancer	1.29e-05	0.000471	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.28e-05	0.000467	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.26e-05	0.000461	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—APRT—kidney cancer	1.26e-05	0.000459	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—FH—kidney cancer	1.26e-05	0.000459	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.25e-05	0.000457	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.23e-05	0.000449	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—POMC—kidney cancer	1.22e-05	0.000446	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.21e-05	0.000442	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PGK1—kidney cancer	1.21e-05	0.000442	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.2e-05	0.000438	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PGK1—kidney cancer	1.2e-05	0.000438	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—LDHB—kidney cancer	1.19e-05	0.000433	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GPC3—kidney cancer	1.18e-05	0.000432	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GSTP1—kidney cancer	1.18e-05	0.000431	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—LDHB—kidney cancer	1.18e-05	0.00043	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CA2—kidney cancer	1.15e-05	0.00042	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALAD—kidney cancer	1.12e-05	0.000409	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CA9—kidney cancer	1.12e-05	0.000408	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ABCB1—kidney cancer	1.12e-05	0.000408	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.09e-05	0.000399	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.09e-05	0.000399	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GSTM1—kidney cancer	1.08e-05	0.000396	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.07e-05	0.00039	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CA9—kidney cancer	1.03e-05	0.000376	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP1A1—kidney cancer	1.03e-05	0.000376	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PGK1—kidney cancer	1.02e-05	0.000374	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.02e-05	0.000374	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CA9—kidney cancer	1.02e-05	0.000372	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—LDHB—kidney cancer	1e-05	0.000367	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.96e-06	0.000364	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTGS2—kidney cancer	9.74e-06	0.000356	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CRABP1—kidney cancer	9.5e-06	0.000347	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ITPR2—kidney cancer	8.83e-06	0.000323	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CRABP1—kidney cancer	8.74e-06	0.000319	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CA9—kidney cancer	8.71e-06	0.000318	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CRABP1—kidney cancer	8.66e-06	0.000317	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.51e-06	0.000311	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTEN—kidney cancer	8.49e-06	0.00031	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.14e-06	0.000298	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ITPR2—kidney cancer	8.12e-06	0.000297	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ACHE—kidney cancer	8.05e-06	0.000294	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTT1—kidney cancer	8.05e-06	0.000294	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ITPR2—kidney cancer	8.05e-06	0.000294	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—POMC—kidney cancer	7.66e-06	0.00028	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SCARB1—kidney cancer	7.62e-06	0.000279	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTGS1—kidney cancer	7.55e-06	0.000276	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.42e-06	0.000271	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ACHE—kidney cancer	7.41e-06	0.000271	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTT1—kidney cancer	7.41e-06	0.000271	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CRABP1—kidney cancer	7.4e-06	0.000271	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PSMD7—kidney cancer	7.4e-06	0.000271	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ACHE—kidney cancer	7.34e-06	0.000268	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTT1—kidney cancer	7.34e-06	0.000268	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—BCHE—kidney cancer	7.02e-06	0.000256	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SCARB1—kidney cancer	7.01e-06	0.000256	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SCARB1—kidney cancer	6.95e-06	0.000254	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTGS1—kidney cancer	6.94e-06	0.000254	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLC5A5—kidney cancer	6.93e-06	0.000253	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ITPR2—kidney cancer	6.88e-06	0.000252	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTGS1—kidney cancer	6.88e-06	0.000252	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PSMD7—kidney cancer	6.81e-06	0.000249	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PSMD7—kidney cancer	6.75e-06	0.000247	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLC2A1—kidney cancer	6.69e-06	0.000245	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.49e-06	0.000237	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—BCHE—kidney cancer	6.45e-06	0.000236	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—BCHE—kidney cancer	6.4e-06	0.000234	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC5A5—kidney cancer	6.38e-06	0.000233	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.34e-06	0.000232	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC5A5—kidney cancer	6.32e-06	0.000231	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ACHE—kidney cancer	6.28e-06	0.000229	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTT1—kidney cancer	6.28e-06	0.000229	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC2A1—kidney cancer	6.16e-06	0.000225	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTGS2—kidney cancer	6.11e-06	0.000223	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC2A1—kidney cancer	6.1e-06	0.000223	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CA—kidney cancer	5.99e-06	0.000219	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SCARB1—kidney cancer	5.94e-06	0.000217	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.92e-06	0.000216	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTGS1—kidney cancer	5.88e-06	0.000215	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PSMD7—kidney cancer	5.77e-06	0.000211	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.66e-06	0.000207	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTP1—kidney cancer	5.58e-06	0.000204	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—BCHE—kidney cancer	5.47e-06	0.0002	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC5A5—kidney cancer	5.4e-06	0.000197	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTEN—kidney cancer	5.33e-06	0.000195	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ABCB1—kidney cancer	5.29e-06	0.000193	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC2A1—kidney cancer	5.22e-06	0.000191	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.16e-06	0.000189	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTP1—kidney cancer	5.14e-06	0.000188	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTM1—kidney cancer	5.13e-06	0.000188	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTP1—kidney cancer	5.09e-06	0.000186	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.06e-06	0.000185	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP1A1—kidney cancer	4.86e-06	0.000178	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ABCB1—kidney cancer	4.86e-06	0.000178	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ABCB1—kidney cancer	4.82e-06	0.000176	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTM1—kidney cancer	4.72e-06	0.000172	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTM1—kidney cancer	4.68e-06	0.000171	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP1A1—kidney cancer	4.47e-06	0.000164	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.43e-06	0.000162	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.41e-06	0.000161	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTP1—kidney cancer	4.35e-06	0.000159	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ABCB1—kidney cancer	4.12e-06	0.000151	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTM1—kidney cancer	4e-06	0.000146	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4e-06	0.000146	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP1A1—kidney cancer	3.79e-06	0.000139	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CA—kidney cancer	3.76e-06	0.000137	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.64e-06	0.000133	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—POMC—kidney cancer	3.63e-06	0.000133	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—POMC—kidney cancer	3.34e-06	0.000122	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—POMC—kidney cancer	3.31e-06	0.000121	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.11e-06	0.000114	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTGS2—kidney cancer	2.89e-06	0.000106	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—POMC—kidney cancer	2.83e-06	0.000103	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTGS2—kidney cancer	2.66e-06	9.72e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTGS2—kidney cancer	2.64e-06	9.64e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTEN—kidney cancer	2.52e-06	9.22e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTEN—kidney cancer	2.32e-06	8.48e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTEN—kidney cancer	2.3e-06	8.41e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTGS2—kidney cancer	2.25e-06	8.24e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTEN—kidney cancer	1.97e-06	7.18e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.78e-06	6.5e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.64e-06	5.98e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.62e-06	5.93e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.39e-06	5.07e-05	CbGpPWpGaD
